Our data demonstrate the importance of assessing noncoding variants in genetic diseases, and show the great potential of splice modulation therapy for deep-intronic variants.
No takes yet. Share an insight, caveat, or question.
Sangermano et al. (2019) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: